David R. Epstein
Director · AgomAb Therapeutics NV
Individual8 10b5-1 trades
- 2024
- Oct 9, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David R. Epstein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric P. Lefkofsky - $155.42M in TEM purchases and sales in the last 12 months
- Ryan Fukushima - $12.60M in TEM purchases and sales in the last 12 months
- James William Rogers - $5.46M in TEM purchases and sales in the last 12 months
- Andrew Polovin - $5.03M in TEM purchases and sales in the last 12 months
- Thomas Edward Schoenherr - $2.06M in TEM purchases and sales in the last 12 months
- Ryan M. Bartolucci - $1.31M in TEM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David R. Epstein?
David R. Epstein is a corporate insider, tracked as Director of AgomAb Therapeutics NV (AGMB). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David R. Epstein submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has David R. Epstein been buying or selling stock?
Recorded transactions: 3 open-market purchases ($131K) and 10 open-market sales ($196K) across all tracked filings.
